查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495406

固态器官移植排斥市场：按交付项目、器官类型、排斥类型、最终用户划分 - 全球预测 2024-2030

Solid Organ Transplantation Rejection Market by Offering (Diagnosis & Testing Solutions, Medications), Organ Type (Heart, Kidneys, Liver), Rejection Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

固态器官移植排斥市场规模预估2023年为77.9亿美元，2024年达81.5亿美元，2030年达108.9亿美元，预估复合年增率为4.90%。

固态器官移植涉及肺、心臟、肾臟和肝臟等重要器官的替代，可显着提高患者的生存率和生活品质。固态器官移植排斥是受者免疫系统将移植器官识别为异物并对固态器官造成损害的过程，需要药物治疗和治疗。全球遭受器官衰竭的人数正在增加，这主要是由于慢性病、老龄化和生活方式因素造成的。随着器官移植需求的增加，对有效排斥管理解决方案的需求也增加。器官移植的增加将推动市场成长。此外，公众和专业人士对固态器官移植进步和排斥管理技术改进的认识的提高也对市场成长做出了重大贡献。然而，固态器官移植涉及复杂且昂贵的医疗程序，例如移植前筛检、手术本身、术后护理以及持续的免疫抑制治疗，导致费用高昂，尤其是在欠发达地区，患者可能会面临高昂的费用。改进的免疫抑制治疗方法的不断开拓提供了透过降低移植后器官排斥的发生率来扩大市场的机会。

主要市场统计
基准年[2023] 77.9亿美元
预测年份 [2024] 81.5亿美元
预测年份 [2030] 108.9亿美元
复合年增长率（%） 4.90%

区域洞察

美洲地区，尤其是美国，由于医疗设施先进、医疗体系发达，器官移植的普及很高。该地区拥有强大的器官移植网络和大量的移植手术，因此对抗排斥药物和治疗的需求很高。这些产品对于抑制移植器官的免疫反应至关重要。由于强有力的监管支持和大量的医疗保健支出，美国在采用新的先进治疗方法方面也处于领先地位。亚太地区显示固态器官移植排斥市场的成长。这是由于医疗基础设施的增加、治疗成本降低而导致的医疗旅游业的增加以及对移植作为慢性病的可行选择的认识的提高所推动的。印度和中国等国家的移植数量正在增加。由于器官移植手术数量的增加以及对移植排斥的认识不断增强，欧洲、中东和非洲地区的固态移植排斥干预市场呈现显着成长。欧洲拥有完善的医疗保健体系和完善的法律规范。受医疗基础设施改善和移植计画国际合作的影响，中东和非洲正在经历适度成长。

FPNV定位矩阵

FPNV 定位矩阵对于评估固态器官移植排斥市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对固态器官移植排斥市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对固态器官移植排斥市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的器官移植数量正在增加。
      • 人们越来越认识到移植和排斥反应管理的进步
    • 抑制因素
      • 移植手术相关的高费用
    • 机会
      • 免疫抑制治疗和监测技术的进展
      • 基因测试的出现提高了排斥风险的准确预测
    • 任务
      • 与免疫抑制治疗相关的复杂性
  • 市场区隔分析
    • 提议：治疗移植器官排斥的药物需求增加
    • 最终使用者：固态器官移植排斥反应广泛应用于医院管理
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章固态器官移植拒绝市场：依报价

  • 诊断和测试解决方案
  • 药品

第七章依器官类型固态的实体器官移植排斥市场

  • 心
  • 肾
  • 肝
  • 肺
  • 胰臟

第八章固态器官移植排斥反应市场（依排斥类型）

  • 急性排斥反应
  • 慢性排斥反应
  • 超急性排斥反应

第九章固态器官移植排斥市场：依最终用户分类

  • 医院
  • 专科诊所

第十章美洲固态器官移植排斥市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太固态器官移植排斥市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲固态器官移植排斥市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 开创性合作旨在预防器官移植排斥取得突破
    • 移植后监测新进展：即时电子器官健康追踪器
    • GenDx 获得都灵大学 cfDNA 检测许可，以加强肺移植监测
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-CB04E05661AD

[181 Pages Report] The Solid Organ Transplantation Rejection Market size was estimated at USD 7.79 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 4.90% to reach USD 10.89 billion by 2030.

Solid organ transplantation, encompassing the replacement of vital organs, including the lungs, heart, kidneys, or liver, markedly improves patient survival and quality of life. Solid organ transplantation rejection is a process in which a recipient's immune system identifies the transplanted organ as foreign and causes damage to the transplanted organ, creating the need for solid organ transplantation rejection medications and therapies. There is a rising number of individuals worldwide who suffer from organ failures, primarily due to chronic diseases, aging, and lifestyle factors. As the demand for organ transplants increases, the requirement for effective rejection management solutions also increases. This rise in organ transplantation propels the market growth. In addition, the rising public and professional awareness of advancements in solid organ transplantation and improved rejection management techniques significantly contribute to market growth. However, solid organ transplantation involves complex and costly medical procedures, including pre-transplant screenings, the surgery itself, post-operative care, and ongoing immunosuppression treatments, which require high costs and can be a significant barrier to market growth, as they may limit transplantation's accessibility for patients and strain healthcare budgets, particularly in less economically developed regions. The ongoing development of refined immunosuppressive treatments offers the opportunity for market expansion by reducing the incidence of organ rejection post-transplant.

KEY MARKET STATISTICS
Base Year [2023] USD 7.79 billion
Estimated Year [2024] USD 8.15 billion
Forecast Year [2030] USD 10.89 billion
CAGR (%) 4.90%

Regional Insights

In the Americas, particularly the United States, there is a high prevalence of organ transplants due to advanced medical facilities and a well-structured healthcare system. This region has a robust organ transplantation network and showcases a significant number of transplant procedures, leading to a substantial need for anti-rejection drugs and therapies. These products are essential to help in reducing the immune response against transplanted organs. The U.S. also leads in adopting new and advanced therapies due to strong regulatory support and substantial healthcare spending. The Asia-Pacific region is showcasing growth in the solid organ transplant rejection market, propelled by increasing healthcare infrastructure, rising medical tourism due to lower treatment costs, and growing awareness about transplantation as a viable option for chronic diseases. Countries, including India and China are seeing increased numbers of transplantations. The market for solid organ transplant rejection interventions in the EMEA region showcases significant growth due to increasing organ transplant procedures and heightened awareness about transplant rejection. Europe has well-established healthcare systems and supportive regulatory frameworks. The Middle East and Africa are witnessing gradual growth, influenced by improving healthcare infrastructure and international collaborations for transplant programs.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Solid Organ Transplantation Rejection Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing number of organ transplants worldwide
      • Rising awareness about the advancements in transplantation and rejection management
    • Market Restraints
      • High costs associated with transplantation procedures
    • Market Opportunities
      • Advancements in immunosuppressive treatments and monitoring technologies
      • Emergence of genetic testing to improve predicting rejection risks accurately
    • Market Challenges
      • Complexities associated with immunosuppressive therapies
  • Market Segmentation Analysis
    • Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Solid Organ Transplantation Rejection Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Solid Organ Transplantation Rejection Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention

Taiwan Bio and TRACT Therapeutics collaborated on cutting-edge cellular therapy aimed at transforming the prevention of allograft rejection in solid organ transplants. This new alliance enhanced a Phase 2 clinical trial across multiple centers in the U.S. and Taiwan, focusing on decreasing the reliance on immunosuppressant drugs in recipients of kidney transplants from living donors. Combining Taiwan Bio's expertise in cellular therapy manufacturing with TRACT Therapeutics' innovative regulatory T-cell therapy platform, this partnership aims to significantly enhance transplant outcomes while improving patients' quality of life. [Published On: 2023-12-06]

New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker

Researchers at Northwestern University innovated the first electronic device designed for continuous, real-time health monitoring of transplanted organs. This study introduces a novel, ultrathin sensor that sits atop transplanted kidneys to monitor for temperature anomalies indicative of inflammation or other complications, which could signal rejection. The device enhances patient safety by wirelessly transmitting data directly to healthcare providers via smartphone or tablet, ensuring immediate medical response to potential issues. [Published On: 2023-09-08]

GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring

GenDx, a Dutch company, has obtained exclusive licensing rights for a cell-free DNA (cfDNA) assay from Torino University. This innovative diagnostic tool is specifically designed to detect and monitor organ rejection in lung transplant recipients. The cfDNA assay offers a non-invasive method to identify early signs of rejection, which is crucial for the timely intervention and management of transplant patients. This advancement promises to enhance post-transplant care by facilitating continuous monitoring and potentially improving patient outcomes. [Published On: 2023-05-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Solid Organ Transplantation Rejection Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Solid Organ Transplantation Rejection Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare Limited, Asahi Kasei Corporation, Astellas Pharma Inc., Biocon, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Eris Lifesciences Ltd., Eurofins Transplant Diagnostics, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Globela Pharma, Lupin Limited, Manus Aktteva Biopharma LLP, Natco Pharma Ltd., Novartis AG, Panacea Biotec Pharma Ltd., Pfizer Inc., Plexision, Sanofi S.A., SAS Alsachim by Shimadzu Group, Strides Pharma Global Pte Ltd., Teva Pharmaceuticals Inc., Thermo Fisher Scientific Inc., Veloxis Pharmaceuticals A/S, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Solid Organ Transplantation Rejection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Diagnosis & Testing Solutions
      • Biopsy
      • Blood Tests
      • Imaging Tests
    • Medications
      • Antibodies
      • Antimetabolites
      • Calcineurin Inhibitors
      • Steroids
  • Organ Type
    • Heart
    • Kidneys
    • Liver
    • Lungs
    • Pancreas
  • Rejection Type
    • Acute Rejection
    • Chronic Rejection
    • Hyperacute Rejection
  • End-User
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of organ transplants worldwide
      • 5.1.1.2. Rising awareness about the advancements in transplantation and rejection management
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transplantation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunosuppressive treatments and monitoring technologies
      • 5.1.3.2. Emergence of genetic testing to improve predicting rejection risks accurately
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with immunosuppressive therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • 5.2.2. End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Solid Organ Transplantation Rejection Market, by Offering

  • 6.1. Introduction
  • 6.2. Diagnosis & Testing Solutions
  • 6.3. Medications

7. Solid Organ Transplantation Rejection Market, by Organ Type

  • 7.1. Introduction
  • 7.2. Heart
  • 7.3. Kidneys
  • 7.4. Liver
  • 7.5. Lungs
  • 7.6. Pancreas

8. Solid Organ Transplantation Rejection Market, by Rejection Type

  • 8.1. Introduction
  • 8.2. Acute Rejection
  • 8.3. Chronic Rejection
  • 8.4. Hyperacute Rejection

9. Solid Organ Transplantation Rejection Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Solid Organ Transplantation Rejection Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Solid Organ Transplantation Rejection Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Solid Organ Transplantation Rejection Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention
    • 13.3.2. New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker
    • 13.3.3. GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET RESEARCH PROCESS
  • FIGURE 2. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SOLID ORGAN TRANSPLANTATION REJECTION MARKET DYNAMICS
  • FIGURE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLIO